These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 5949835

  • 1. [Case of Rh incompatibility surviving after exchange transfusion].
    Matsuyama S, Morikawa N, Shibata J, Seto C, Hayashi A.
    Iryo; 1966 Jan; 20(1):92-4. PubMed ID: 5949835
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical follow-up studies on late prognosis of Rh-related hemolytic disease of the newborn. VII. Indications for exchange transfusion in Rh-incompatibility].
    Schneeweiss B.
    Padiatr Grenzgeb; 1970 Jan; 9(3):208-17. PubMed ID: 4997628
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Hemoglobin level and erythrocyte count in children up to 2 years old treated by exchange transfusions because of blood incompatibility].
    Rudkowski Z, Prandota A, Czarnecka M, Bohdanowicz E.
    Pediatr Pol; 1969 Dec; 44(12):1487-93. PubMed ID: 4984229
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Erythropoietic activity in newborn infants with maternal-fetal incompatibility in the ABO system treated with exchange transfusion. Use of the Ashby method in 14 cases].
    Stegagno G, Mencarini L, Orvieto G.
    Minerva Pediatr; 1968 Oct 13; 20(41):2131-42. PubMed ID: 5754726
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Diagnostic and therapeutic measures in materno-fetal Rh-factor isoimmunization].
    Paladini A, Di Martino D, De Luca P, Rascio B, Di Lieto A.
    Arch Ostet Ginecol; 1969 Dec 13; 74(6):476-94. PubMed ID: 5000274
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [A few remarks of the immunohematologist in connection with administration of exchange transfusions in the newborn with hemolytic disease (with respect to the transfusion material)].
    Kulich V, Sauer J.
    Cesk Gynekol; 1969 Oct 13; 34(8):488-90. PubMed ID: 5354332
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [On the wait-and-see attitude in the management of newborns with Rh erythroblastosis].
    Dortmann A, Küster F, Stapper H.
    Arch Kinderheilkd; 1967 May 13; 175(3):236-42. PubMed ID: 4967237
    [No Abstract] [Full Text] [Related]

  • 17. [Blood chemical parameters in newborn infants with fetal erythroblastosis during exchange transfusion].
    Macchia A, Gori A, De Punzio C, Baisi F.
    Minerva Ginecol; 1981 Jun 13; 33(6):548-53. PubMed ID: 7197006
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV, Beck ML.
    Clin Haematol; 1984 Feb 13; 13(1):167-83. PubMed ID: 6327130
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.